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Abstract:
The practice of long- and medium-distance races has exponentially increased the number of participants in 
recent years. They are carried out under extreme conditions that cause both biochemical and anthropometric 
changes in athletes and, in addition, have serious risks associated, such as dehydration, thermal disorders, 
or hypoglycemia. Knowledge regarding alterations at hematological level after this type of effort is limited. 
The objectives of this pre-post analytical descriptive observational study were: to describe and compare 
hematological values in amateur runners pre and post road marathon and ultratrail races, and to compare 
the hematological parameters between the groups measured at two time points analyzed by means of 
univariate descriptive statistical analyses, intra-group pre-post comparisons (Wilcoxon Signed-Rank Test), 
and comparisons between the groups (Mann-Whitney U Test). Effect size was calculated using Cohen’s d. An 
explanatory model (Multiple Logistic Regression) was created. Statistical significance was set at p<.05. The 
Wilcoxon test for marathon runners observed significant differences (p≤.001) in the white series. In ultratrail 
runners, the results were similar, with significant differences (p≤.001) in the platelet series. The Mann-
Whitney U test showed the same pre-race hematological conditions for both groups, except for hematocrit 
and corpuscular values (p≤.001). Significant differences (p≤.001) were also found in the post-race leukocyte 
and neutrophil values. Significant differences in hematological parameters have been observed both between 
and within the groups. The differences with greater significance corresponded to the leukocyte series.
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Introduction
In recent decades, a positive relationship has 
been recognized between an optimal state of 
health and the regular practice of physical exer-
cise (Sánchez-González, Rivera-Cisneros, & Tovar, 
2003), in addition to a decrease in mortality in 
athletes compared to sedentary individuals (Müler, 
et al., 2017; Schwarz, et al., 2018). All this has led to 
a notable boom in sports, especially in those activ-
ities related to medium- and long-distance races. 
Both, road and trail marathons have exponentially 
increased their number of participants in recent 
years worldwide (Areces, et al., 2014; Nikolaidis 
& Knechtle, 2018; Rama, Minuzzi, Carvalho, 
Costa, & Teixeira, 2016; Wu, et al., 2004). This 
popularity is evidenced in the increase of sporting 
events, as can be seen in the information offered by 
the International Association of Athletics Federa-
tions (IAAF), which reports more than ten thou-
sand competitions registered per year worldwide.
Medium- and long-distance races, especially 
marathons, characterized by exceeding the distance 
of 42 km, and ultratrails, which involve the comple-
tion of 115 km, are usually carried out under extreme 
environmental conditions (Hoffman & Fogard, 
2011; Knechtle, 2012; Rama, et al., 2016). Physical 
capabilities and technical skills required for moun-
tain races and marathons are quite different from 
each other. The orography of terrain, altitude, air 
temperature and the presence or lack of inclines, 
among other variables, make mountain races and 
marathons differ in their characteristics and in 
requirements runners need to meet to face them 
(Clemente, 2011). Moreover, runners’ performance 
will be influenced by environmental factors and 
internal factors, among which we can include age, 
sex, anthropometry, running technique, as well as 
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training habits (Areces, et al. 2014). Therefore, the 
effort required will vary between two types of races 
(Clemente, 2011). 
Marathon races’ speed and duration of ultrat-
rails subject the athlete’s organism to strenuous 
conditions. Such exposure to stress causes a 
decrease in strength and loss of muscle mass along 
with the appearance of muscle damage. This can 
be evidenced by high levels of myoglobin, creatine 
kinase (CK), alanine aminotransferase (ALT) and 
hydroxybutyrate dehydrogenase, together with a 
notable elevation of lactic dehydrogenase (LDH) 
and troponins (Bernat-Adell, et al., 2019; Clemente, 
2011; Hoffman, Ingwerson, Rogers, Hew-Butler, & 
Stuempfle, 2012; Nie, et al., 2011) in the blood. Such 
modifications remain altered for days in adults. 
At the end of any long-distance race, decreased 
triglyceride values are usually present since lipids 
are considered the main source of energy, while 
glucose can be altered in relation to carbohydrate 
consumption throughout the race (Clemente, 2011).
It is important to highlight risks linked to this 
type of sport practices that can compromise health 
and even life of runners. Among them are extreme 
fatigue, thermal and dehydration disorders, hypo-
glycemia or acute coronary syndrome that can lead 
to acute myocardial infarction (Sánchez-González, 
et al., 2003) although literature only indicates a 
prevalence of one sudden death for every fifty-five 
thousand runners in the first decade of this century 
(Roberts & Maron, 2005).
Regarding alterations at the hematological level, 
changes and alterations in the blood count have 
been observed, which influence both the red and 
white series with high levels of hemolysis being 
determined after strenuous exercise (Kratz, et 
al., 2002; Peters, Robson, Kleinveldt, Naicker, & 
Jogessar, 2004; Robach, et al., 2014; Ruiz Vicente, 
et al., 2013).
The consequence of exercise-induced hemolysis 
or “sports anemia” is primarily related to hemodi-
lution, which is defined as an increase in plasma 
volume that exceeds the increase in the total mass 
of red blood cells and causes a reduction in their 
recount as well as a reduction in hemoglobin (Hb) 
or hematocrit (Htc). The cause of sports anemia is 
multifactorial and may be motivated by oxidative 
stress induced by exercise, iron deficiency, gastro-
intestinal bleeding, hematuria and hemolysis being 
a result of continuous foot strokes and is not always 
related to the massive destruction of red blood cells 
(Chiu, et al., 2015; Robach, et al., 2014). Most studies 
on hematological parameters have been carried out 
with professional runners, whose characteristics 
may differ from those that define amateur runners 
(Ruiz-Vicente, et al., 2013), so it is interesting to 
know more precisely the variations of hematolog-
ical parameters in amateur marathon and ultrat-
rail runners. Knowing hematological deviations in 
non-professional runners may be helpful for runners 
themselves to improve their performance as well as 
for coaches and medical staff. 
Objectives
The objectives were to determine the hemato-
logical values in amateur runners pre and post road 
marathon and pre and post ultratrail; to compare the 
within- and between-group hematological param-
eters obtained at two time points, and to determine 
the relationship between the hematological vari-
ables and age, sex, body mass index (BMI) and 
running time.
Methods
A descriptive and comparative observational 
study was performed. The hematological values 
were compared in two stages: pre- and post-race 
within each group and then between the groups.
Population of the road marathon group
The population of marathon runners were the 
participants in the Trinidad Alfonso EDP Marathon, 
held in the city of Valencia on November 20th, 2016 
(N=18,800). They previously received a commu-
nication via email describing the characteristics 
of the study with the request for their participa-
tion. A total of 456 runners responded, all of them 
non-professional athletes. The sample was formed 
by the runners who voluntarily gave their explicit 
consent to participate in the study (n1=103 runners) 
and who met the following inclusion criteria: being 
between 30 and 44 years of age, having a body 
mass index (BMI) between 16 and 24.99 kg/m2, 
having previously completed a marathon with an 
accredited time: between 3 hours and 4 hours for 
men and between 3:30 hours and 4:30 hours for 
women, and having passed the medical tests prior to 
the study (electrocardiogram, blood pressure, echo-
cardiography, and stress test). The following exclu-
sion criteria were established: presenting any docu-
mented renal pathology, presenting any documented 
cardiological pathology or history of ischemic heart 
disease in first-degree relatives, and presenting any 
process that involved taking medication continu-
ously.
Population of the ultratrail mountain group
The population of ultratail runners were partici-
pants in the Penyagolosa Trails in the CSP modality, 
of 107.4 km, with an uphill level of 5604 and down-
hill level of 4356 m respectively, which was held on 
May 9th, 2015 (N=600). They previously received a 
communication via email describing the character-
istics of the study with the request for their partic-
ipation. The sample was formed by all those who 
voluntarily gave their explicit consent to partici-
pate in the study (n2=50 runners) and who fulfilled 
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the following inclusion criteria: having previously 
completed a race with a distance greater than 60 
km and having passed the medical tests prior to 
the study (electrocardiogram and blood pressure). 
The following exclusion criteria were established: 
being under 18 or over 65 years of age, having been 
hospitalized during the previous year, presenting 
a history of cardiovascular or renal pathology, 
suffering from any type of neoplasia, inflamma-
tory or infectious disease at the time of the study, 
having presented a hemorrhagic event or having 
received a blood transfusion in the previous four 
months or presenting a process that involved taking 
medication continuously.
The final sample size corresponded to a value 
of n=153 runners, resulting from the sum of the 
samples of both groups (n1=103 marathon runners 
and n2=50 ultratrail runners).
Procedure
The data were obtained in the Trinidad Alfonso 
EDP Marathon, which had 42 km and 195 metres 
of route on asphalt and an incline of between one 
and 27 metres above sea level, and in the Peny-
agolosa Trails in the CSP modality, which had a 
total distance of 115 km, with 5,439 metres of posi-
tive slope and 4,227 metres of negative slope. For 
the sample participants in both races, a survey was 
first conducted to know the training habits of each 
participant and their medical history (Hernando, et 
al., 2018). The BMI was determined with the data of 
height and body mass obtained by measuring with a 
SECA-123 stadiometer and a SECA-770 digital floor 
scale. Body mass of the participants was measured 
pre- and post-race. 
For each participant, a total of two blood deter-
minations were performed. Blood samples were 
extracted from an antecubital vein, first of the one 
and then of the other arm. The blood sample was 
collected in Vacutainer® tubes specific for this type 
of analyses and the Roche / Hitachi cobas c analyzer 
was used. The first extraction was made 24 hours 
before the race, at the Runner’s Fair, and the next 
extraction was performed at the finish line. The 
blood samples were transported in cold medium, 
within two hours after the extraction. Samples were 
processed upon arrival at the Hospital 9 d’Octubre 
de Valencia laboratory, in the case of the marathon. 
The mountain race analyses were processed in the 
laboratory of the Jaume I Hospital in Castellón.
Variables
The independent variables were sociodemo-
graphic (age and biological sex) variables, biolog-
ical (BMI, in kg/m2) variables pre- and post-test, 
and the race time variable (which indicated hours 
invested in the race: from start to the finish line).
The dependent variables were the hematolog-
ical parameters studied, including the red blood cell 
count, hematocrit value (Htc), hemoglobin (Hb), 
mean corpuscular volume (MCV), mean corpus-
cular hemoglobin (MCH), mean corpuscular hemo-
globin concentration (MCHC), red cell distribution 
width (RDW), leukocytes, neutrophils, lympho-
cytes, monocytes, eosinophils, basophils, platelets 
and platelet volume.
Data analyses
For the univariate analysis purposes, the quan-
titative and continuous variables were presented as 
means and standard deviations. Qualitative varia-
bles were expressed in frequencies and percentages. 
The Kolmogorov-Smirnov test showed no normal 
distribution of the variables, therefore bivari-
ate analyses were performed using the Wilcoxon 
Signed-Rank Test to observe the intragroup differ-
ences between the values obtained at two time 
points for related samples; to compare the hemato-
logical parameters between the groups across both 
time points, the Mann-Whitney’s U test was used 
for independent samples.
In both statistics, the strength of association was 
measured through the Cohen’s d; being non-para-
metric statistics, the expression of Cohen’s d for 
the Wilcoxon test was expressed in rbis and for the 
Mann-Whitney’s U test in dpppc2.
The influence of the independent variables on 
the dependent variables in both groups was analyzed 
using multiple logistic regression. The analyzes 
were performed using IBM SPSS® version 25. A 
value of p<.05 was accepted as statistically signif-
icant.
Ethical considerations
The present study was approved by the Deon-
tological Commission of the Jaume I University. 
The study has respected the Declaration of Helsinki 
(WMA, 2013) guidelines for studies with human 
beings. Random numbers were created from the 
bib number of each runner to anonymize personal 
data. The data is kept in archives protected by the 
principal investigator of the project at the Jaume I 
University. 
The volunteers were informed of the objec-
tives, risks, and benefits of the study, and signed 
an informed consent authorizing their participa-
tion. In the case of the marathon test, the study 
protocol was approved in May 2016. The project is 
registered in the ClinicalTrials.gov database with 
code NCT 03155633.
Results
A total of 119 runners took part in the study. 
The total sample consisted of 103 men (86.6%) 
and 16 women (13.4%), out of whom 84 (men 
85.7% and women 14.3%) were marathon runners 
and 35 (men 88.6% and women 11.4%) ultratrail 
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runners. The mean age was 38.55±3.62 years for 
the marathon runners and 39.2±7.34 years for the 
ultratrail runners. The BMI at Runner’s Fair was 
23.03±1.68 kg/m2 in the road marathon group, 
which at the finish line decreased to 22.6±1.52 
kg/m2. In the case of the ultratrail group, the 
mean BMI value was 24.09±2.38 kg/m2, which 
decreased to 23.42±2.31 kg/m2 after the race. The 
mean race time used to complete the 42 km of 
the marathon was 3hours:34minutes:54seconds 
(±20minutes:45seconds) versus the mean time of 
22hours:25minutes:47seconds (±3hours:44minutes:
41seconds) that was required to complete the ultrat-
rail. Table 1 shows the descriptive results of both 
races. 
After the descriptive analysis, an intragroup 
comparison was performed using the Wilcoxon test. 
The results of analyzing the differences between 
the pre- and post-race hematological parameters 
for both groups are shown in Table 2. 







M±SD M±SD M±SD M±SD
Red blood cells (10^12/L) 4.94±.34 4.79±.32 4.98±.34 4.79±.38
Hemoglobin (g/dL) 14.7±.93 14.36±1.08 14.84±1 14.43±1.25
Hematocrit (%) 45.25±2.57 41.93±2.62 45.07±2.74 41.33±3.09
MCV (fL) 91.75±3.73 87.78±30.04 90.6±3.72 86.42±4.28
MCH (pg) 29.77±1.4 30.04±1.58 29.82±1.39 30.14±1.61
MCHC (g/dL) 32.45±.75 34.22±.79 36.59±33.73 34.88±.98
RDW 13.16±.67 13.28±.74 12.95±.58 13.2±.8
Leukocytes (10^9/L) 9.04±11.29 6.56±1.76 17.36±3.94 13.42±2.69
Neutrophils (10^9/L) 4.12±1.33 3.69±1.37 14.48±3.66 10.14±2.54
Lymphocytes (10^9/L) 2.25±.67 2.05±.52 1.58±.60 1.88±.53
Monocytes (10^9/L) .54±.15 0.58±.18 1.22±.38 1.30±.44
Eosinophils (10^9/L) .19±.13 0.17±.14 .03±.04 0.04±.06
Basophils (10^9/L) .03±.01 0.03±.01 .03±.01 0,02±.01
Platelets (10^9/L) 220.25±39.97 219.88±44.32 256.36±50.87 249.25±44.33
Platelet Vol. (fL) 11.4±.74 4.79±.32 11.59±.82 4.79±0.38
Note. Mean value expressed as (M). Value of the standard deviation expressed with (SD). MCV: mean corpuscular volume. MCH: 
mean corpuscular hemoglobin. RDW: red blood cell distribution width.
Table 2. Wilcoxon test
Road marathon Ultratrail
Variable Z p rbis Z p rbis
Red blood cells -1.110 .267 .918 -.303 .762 .966
Hemoglobin -1.953 .051 .816 -.534 .594 .878
Hematocrit -1.403 .160 .893 -1.696 .090 .968
MCV -6.805 <.0001*** .952 -4.284 <.0001*** .998
MCH -1.995 .046* .892 -1.356 .175 .989
MCHC -6.522 <.0001*** .812 -4.154 <.0001*** .743
RDW -5.647 <.0001*** .660 -2.353 .019* .975
Leukocytes -6.859 <.0001*** .993 -5.160 <.0001*** .833
Neutrophils -7.961 <.0001*** .692 -5.086 <.0001*** 1
Lymphocytes -6.505 <.0001*** .762 -2.154 .031* .912
Monocytes -7.909 <.0001*** .887 -5.160 <.0001*** .548
Eosinophils -7.945 <.0001*** .266 -5.072 <.0001*** .770
Basophils -1.459 .145 .334 -.667 .505 .578
Platelets -7.343 <.0001*** .929 -4.540 <.0001*** .988
Platelet Vol. -3.033 .002** .608 -4.633 <.0001*** .876
Note. p value: p<.05*, p<.01**, p <.001*** / There is no difference if the value is between ±1.96. 
Association power – Cohen’s d values (rbis): .2-.3 low / .5-.7 medium / >.8 strong 
MCV: mean corpuscular volume. MCH: mean corpuscular hemoglobin. MCHC: mean corpuscular hemoglobin concentration. RDW: 
red blood cell distribution width.
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In addition, the differences in both pre- and 
post-race hematological parameters between the 
ultratrail and marathon runners were studied using 
a Mann-Whitney’s U test, and the results are repre-
sented in Table 3. The power of association of these 
differences was measured using Cohen’s d in both 
intra- and inter-group comparisons. 
Finally, a prediction map was generated using 
multiple linear regressions with the intro method to 
explain the differences found in the pre- and post-
race hematolological parameters for runners of each 
type of race. A level of confidence was accepted 
(CI=95%). The integrated variables were age, sex, 
BMI, and running time. The last variable only 
took into account post-race values. The results are 
shown in Table 4. 
Table 3. Mann-Whitney’s U test
Pre Post dppc2
Red blood cells .019* .021* .119
Hemoglobin .095 .157 .072
Hematocrit <.0001*** <.0001*** .162
MCV <.0001*** <.0001*** .054
MCH .266 .284 -.034
MCHC <.0001*** <.0001*** 4.558
RDW .392 .136 -.188
Leukocytes .036* <.0001*** .152
Neutrophils .055 <.0001*** 2.908
Lymphocytes .222 .003* -.792
Monocytes .949 .675 .439
Eosinophils .308 .605 -.225
Basophils .647 .057 .998
Platelets .984 .111 1.09
Platelet Vol. .001** .241 .256
Note. p value: p<.05*, p<.01**, p<.001***. Association power – Cohen’s d values (dppc2): .2-.3 low /. 5-.7 medium / >.8 strong. MCV: 
mean corpuscular volume. MCH: mean corpuscular hemoglobin. RDW: red blood cell distribution width. MCHC: mean corpuscular 
hemoglobin concentration.
Table 4. Results obtained by applying a prediction map
Pre Post
Test p R Test p R
Hematocrit
M <.0001*** 31.8% M <.0001*** 31%
U .076 19.6% U .414 11.9%
Red blood cells
M .554 1.7% M .280 5.4%
U .020* 24.3% U .387 10.4%
MCV
M .344 4% M .563 3.6%
U .472 7.7% U .367 13%
MCHC
M .007** 14.1% M .404 4.9%
U .151 15.5% U .395 12.3%
Leukocytes
M .853 1% M .215 7%
U .021* 26.6% U .107 21.8%
Neutrophils
M .481 3% M .358 5.3%
U .028* 25.2% U .149 19.6%
Lymphocytes
M .511 2.8% M .645 3.1%
U .121 16.8% U .028* 29.7%
Platelet Vol.
M .736 1.6% M .589 3.5%
U .635 5.3% U .635 5.3%
Note. p value: p<.05*, p<.01**, p<.001***. M = marathon. U = ultratrail.
MCV: mean corpuscular volume. MCHC: mean corpuscular hemoglobin concentration.
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Discussion and conclusions
There are few studies that analyze hematolog-
ical changes in medium- and long-distance runners 
in detail (Wu, et al., 2004). The results of this study 
allow us to describe the characteristics of hemato-
logical values in amateur marathon and ultratrail 
runners as well as to show which hematological 
values change between baseline (pre-race) and the 
finish line in both groups. The changes observed 
were similar in both the road marathon group and 
the ultratrail mountain group, although the condi-
tions of both tests were different.
Regarding the red blood cells, no significant 
differences were evidenced. In the case of marathon 
runners, there was a slight increase, while in ultrat-
rail mountain runners the values remained almost 
the same. Similar results were obtained by Minuzzi, 
Teixeira, Carvalho, da Costa, and Rama (2018), 
who also did not find significant differences in the 
values of Hb and Htc. The differences in hemo-
globin and hematocrit were not significant, with 
a slight increase in hemoglobin values, while the 
hematocrit remained constant. These results were 
similar to those obtained by Clemente (2011) and 
Robach et al. (2014). Previous studies did determine 
significant changes between baseline and finish line 
conditions in the case of marathon runners; Duca et 
al. (2006) showed a significant increase in the post-
marathon red blood cell count without presenting 
changes in hemoglobin values; Nuviala, Lapieza, 
Anson, Castillo, and Giner (1995) found signifi-
cant increases in red blood cell count, hemoglobin 
and hematocrit. However, Sierra et al. (2019), in a 
sample of similar characteristics, found a signifi-
cant reduction in the hematocrit value in marathon 
runners, and this reduction remained significant 
until 15 days after the race. Kratz, Wood, Siegel, 
Hiers, and Van Cott (2006) and Sánchez-González 
et al. (2003) found an increase in hemoglobin, which 
they associated with hemoconcentration, and they 
described an increase in all the variables studied. 
Rama et al. (2016) and Wu et al. (2004) also showed 
a decrease in erythrocyte count, hematocrit and 
hemoglobin at the end of the race in the mountain 
context.
As for the mean corpuscular parameters, signifi-
cant differences were found between both times 
under the study and between both race modali-
ties, with the results showing a strong association 
power. The MCV was reduced after the effort, as 
in previous studies (Kratz, et al., 2002, 2006; Ruiz-
Vicente, et al., 2013), and this difference could be 
the product of oxidative stress associated with great 
efforts that generated alteration of cell homeostasis 
secondary to dehydration, motivating a decrease in 
cell size (Ruiz Vicente, et al., 2013; Wu et al., 2004). 
However, previous studies showed that the MCV 
was increased after a marathon race (Kratz, et al., 
2002; Remacha, 1992; Sánchez-González, et al., 
2003). It should be noted that previous studies with 
mountain runners did not show significant changes 
in any of the corpuscular values according to Wu 
et al. (2004), or showed that the values of MCV 
and MCH remained constant (Rama, et al., 2016; 
Robach, et al., 2014). 
Regarding MCH, significant alterations were 
only found in the marathon group, remaining 
unchanged in the ultratrail runners. Coinciding with 
Wu et al. (2004), the MCHC increased significantly 
in the post-race determination in both groups. Rama 
et al. (2016) associated this increase with hemo-
concentration due to a loss of intracellular fluid in 
erythrocytes. The fact that both the size and the 
corpuscular volume were reduced, in the case of the 
red series cells, coincides with a decreased RDW 
value, unlike in the study by Robach et al. (2014). 
Interestingly, literature supports that a normal 
or decreased value of RDW is associated with a 
lower risk of inflammatory disease (Horta-Baas & 
Romero-Figueroa, 2019). However, and despite the 
differences found, athletes adapt to such changes 
without detriment (Rama, et al., 2016).
With regard to platelets, these significantly 
increased at the end of both races as well as their 
volume, with the difference associated with ultra-
trail athletes being greater and with a strong size 
effect. Similar results were evidenced in previous 
literature, with an increase in absolute platelet 
values, both in road and mountain runners, regard-
less of the distance (Kratz, et al., 2002; Lippi, et 
al. 2010; Minuzzi, et al., 2018; Rama, et al., 2016; 
Remacha, 1992; Ruiz-Vicente, et al., 2013; Sánchez-
González, et al., 2003; Smith, Garbutt, Lopes, & 
Pedoe, 2004; Wu, et al., 2004). In a sample of 99 
runners, Schwarz el al. (2018) obtained similar 
results to this study; in the post-race evaluation, 
leukocytosis, the increase in platelet count together 
with a reduction in lymphocytes were significant. 
These results could be associated with an acute 
response to tissue injury secondary to strenuous 
exercise and direct mechanical stress caused by the 
continuous impacts against the ground throughout 
the test (Clemente, 2011; Kratz, el al., 2006; Rama, 
et al., 2016; Ruiz-Vicente, et al., 2013).
Tissue damage was manifested by leukocytosis 
at the expense of the increase in absolute neutrophil 
values in both the road and mountain runners. The 
results were in accordance with previous studies, as 
both the marathon and the ultratrail are conditioned 
by an inflammatory process at a systemic level, 
without the need for the presence of a pathological 
factor (Coso, et al., 2012; Duca, et al., 2006; Kratz, 
et al., 2006; Lippi, et al., 2010; Neubauer, Reich-
hold, Nersesyan, Konig, & Wagner, 2008; Rama, 
et al., 2016;; Remacha, et al., 1992; Ruiz-Vicente, 
et al., 2013; Smith, et al., 2004; Wu, et al., 2004). 
The decrease in eosinophils presented in both race 
modalities and the decrease in monocytes in the 
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ultratrail runners could be related to muscle damage 
and an increase in the secretion of adrenal hormones 
such as cortisol (Henson, et al., 2019; Rama, et al., 
2016; Sánchez-González, et al., 2003). A significant 
increase in the absolute values of lymphocytes and 
monocytes has been determined, while basophils 
have not changed after exertion.
In general, the changes observed in both groups 
are similar at the hematological level, despite the 
differences in the characteristics and conditions 
of the races. When comparing the baseline condi-
tions of both groups of athletes, significant differ-
ences were found in the value of hematocrit, red 
blood cells, MCV, MCHC, total leukocyte value 
and platelet volume, with a weak association power 
except for MCHC. At the end of the tests, the same 
prior differences were maintained to which changes 
in neutrophils were added, responsible for the early 
and rapid response to situations of muscle injury 
and, less significantly, in lymphocytes. The runners, 
after the completion of 42 km on road or 115 km on 
mountain, finished with the same values in terms of 
platelet count and volume. It should be noted that 
the power of association was mild, despite having 
a reliable significance.
The regression model explained that age, sex, 
and BMI determine some of the differences found 
in the pre-race evaluation in the case of marathon 
runners, affecting baseline hematocrit and MCHC. 
In the post-race evaluation, by adding the running 
time, the model explained only the changes in the 
hematocrit value. In the case of ultratrail runners, 
before starting the test, the variability was given 
by the same factors for the red blood cells, the 
MCHC and in the absolute values of leukocytes and 
neutrophils. At the end of the 115 km, lymphocytes 
were determined by sex, BMI, and age in approx-
imately 30% of cases. It is necessary to continue 
researching in this field in order to obtain more 
conclusive results.
In conclusion, the existence of significant differ-
ences between the baseline and post-race condi-
tions of the runners has been evidenced, in both 
the road marathon and ultratrail mountain runners. 
They were similarly affected, with special interest 
drawn to the changes in corpuscular values and 
in the white series. Furthermore, the comparison 
between the groups, at the pre-race time, started 
with baseline differences in red blood cells, hema-
tocrit, MCV, MCHC, platelet volume and leuko-
cyte count in favor of marathon runners. At the end 
of both tests, the athletes maintained the previous 
differences and added significant differences in the 
absolute values of neutrophils and lymphocytes. 
Finally, it has been determined that the biolog-
ical sex, age, BMI, and running time only explain 
the differences in hematocrit (pre- and post-race) 
and MCHC (at baseline) of marathon runners, while 
in mountain athletes, they explain the changes in 
red blood cells, leukocytes and neutrophils in the 
baseline conditions and the variation in lympho-
cytes at the end of the test.
Limitations of the present study were related 
to the differences between the two races and the 
physical and training differences of the respective 
runners. Regarding the aspects to be improved for 
future studies, the fact of quantifying dehydration 
and hemoconcentration should be included as well 
as monitoring the presence of hemolysis.
It should be noted that these data could be of help 
at a practical level for the interpretation of analytics 
in endurance athletes after prolonged efforts, more 
adjusted to reality than the reference values indi-
cated for the general population. Knowing these, 
hematological changes may help the runner training 
and prevent risks associated with sports of a high 
physical demand. 
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